Menu Close

Gene editing may enhance CAR T-cell therapy for hematologic malignancies

Researchers at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis have used gene editing technology known as CRISPR to engineer human T cells to attack certain cancers. Results from studies conducted …

Date : 2018-07-17T20:39:00.000Z
Source : https://www.healio.com/hematology-oncology/leukemia/news/online/%7B36c82695-07c0-4de6-88a1-db5aba5043cf%7D/gene-editing-may-enhance-car-t-cell-therapy-for-hematologic-malignancies

CAR T-cell therapy ‘quite promising’ for glioblastoma

Chimeric antigen receptor T-cell therapy may overcome some of the obstacles associated with systemic therapy for patients with glioblastoma, according to a review published in Neuro-Oncology. Although progress with chimeric antigen receptor (CAR) T-cell …

Date : 2018-07-17T14:08:00.000Z
Source : https://www.healio.com/hematology-oncology/neuro-oncology/news/online/%7B66c3e2bc-9965-45f7-8d5b-4cf21f380777%7D/car-t-cell-therapy-quite-promising-for-glioblastoma